1. VIP152 is a selective CDK9 inhibitor with pre-clinical in vitro and in vivo efficacy in chronic lymphocytic leukemia
    Steven Sher et al, 2023, Leukemia CrossRef
  2. New insights into redox homeostasis as a therapeutic target in B-cell malignancies
    Agnieszka Graczyk-Jarzynka et al, 2017, Current Opinion in Hematology CrossRef
  3. The contributory roles of histone deacetylases (HDACs) in hematopoiesis regulation and possibilities for pharmacologic interventions in hematologic malignancies
    Mahdieh Mehrpouri et al, 2021, International Immunopharmacology CrossRef
  4. Multivariate transcriptome analysis identifies networks and key drivers of chronic lymphocytic leukemia relapse risk and patient survival
    Ti’ara L. Griffen et al, 2021, BMC Medical Genomics CrossRef

  5. Anti-Oxidant and Anti-Endothelial Dysfunctional Properties of Nano-Selenium in vitro and in vivo of Hyperhomocysteinemic Rats


    Zeqi Zheng et al, 2020, International Journal of Nanomedicine CrossRef
  6. Importance of Crosstalk Between Chronic Lymphocytic Leukemia Cells and the Stromal Microenvironment: Direct Contact, Soluble Factors, and Extracellular Vesicles
    Nathan Dubois et al, 2020, Frontiers in Oncology CrossRef
  7. Stem cell factor is implicated in microenvironmental interactions and cellular dynamics of chronic lymphocytic leukemia
    null George I. Gavriilidis et al, 2020, Haematologica CrossRef
  8. A novel method to investigate drug resistance in the chronic lymphocytic leukemia (CLL) microenvironment: Analysis of CLL Cellular Environment and Response (ACCER)
    Tricia Choquette et al, 2023, Leukemia & Lymphoma CrossRef
  9. Systemic depletion of L-cyst(e)ine with cyst(e)inase increases reactive oxygen species and suppresses tumor growth
    Shira L Cramer et al, 2017, Nature Medicine CrossRef